SCHEMBL5960429

SCHEMBL5960429

CCOC(=O)C(=O)/C=C(\O)CCl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.44
GLO1 Q04760 1/20 0.39
ALDH1A1 P00352 6/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
CYP2D6 P10635 1/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
EGLN1 Q9GZT9 1/20 0.37
HCAR2 Q8TDS4 1/20 0.36
POLB P06746 1/20 0.35
HTT P42858 1/20 0.35
LMNA P02545 1/20 0.34
HSD17B10 Q99714 1/20 0.34
TSHR P16473 1/20 0.34
GAA P10253 2/20 0.33
ALOX15 P16050 1/20 0.33
MGAM O43451 1/20 0.33
SI P14410 1/20 0.33
MGAM2 Q2M2H8 1/20 0.33
CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16501577 0.83 NPSR1 (0.47) NPSR1GLO1ALDH1A1SMN1; SMN2CYP2D6
SCHEMBL20931276 0.79 NPSR1 (0.52) NPSR1GLO1ALDH1A1SMN1; SMN2CYP2D6
SCHEMBL1234195 0.77 FAAH (0.44) NPSR1GLO1ALDH1A1SMN1; SMN2CYP2D6
SCHEMBL1234536 0.77 NPSR1 (0.41) NPSR1GLO1ALDH1A1SMN1; SMN2CYP2D6
SCHEMBL1234534 0.77 NPSR1 (0.41) NPSR1GLO1ALDH1A1SMN1; SMN2CYP2D6
SCHEMBL1234194 0.77 FAAH (0.44) NPSR1GLO1ALDH1A1SMN1; SMN2CYP2D6
SCHEMBL16883788 0.77 NPSR1 (0.48) NPSR1GLO1ALDH1A1SMN1; SMN2CYP2D6
SCHEMBL17619384 0.77 NPSR1 (0.48) NPSR1GLO1ALDH1A1SMN1; SMN2CYP2D6
SCHEMBL4575182 0.74 NPSR1 (0.50) NPSR1GLO1ALDH1A1SMN1; SMN2CYP2D6
SCHEMBL2593351 0.72 NPSR1 (0.48) NPSR1GLO1ALDH1A1SMN1; SMN2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9145410-B2 Pyrazolopyridines and analogs thereof 3M INNOVATIVE PROPERTIES COMPANY (US) 2015-09-29 US disclosed
US-20120121651-A1 PYRAZOLOPYRIDINES AND ANALOGS THEREOF 3M INNOVATIVE PROPERTIES COMPANY 2012-05-17 US disclosed
US-7879849-B2 such as 1-(2-Methylpropyl)-2-propyl-2H-pyrazolo[3,4-c]quinolin-4-amine, used as immunomodulators, for inducing or inhibiting cytokine biosynthesis in animals and in the treatment of viral and neoplastic diseases 3M INNOVATIVE PROPERTIES COMPANY (US) 2011-02-01 US disclosed
US-20090318435-A1 PYRAZOLOPYRIDINES AND ANALOGS THEREOF 3M INNOVATIVE PROPERTIES COMPANY 2009-12-24 US disclosed
US-7544697-B2 Pyrazolopyridines and analogs thereof COLEY PHARMACEUTICAL GROUP, INC. (US) 2009-06-09 US disclosed
US-20090075980-A1 Pyrazolopyridines and Analogs Thereof COLEY PHARMACEUTICAL GROUP, INC. (US) 2009-03-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090075980-A1 Pyrazolopyridines and Analogs Thereof IL4, IL4I1, IL2 NPSR1 2255/4885GLO1 2953/4885ALDH1A1 1406/4885
US-20120121651-A1 PYRAZOLOPYRIDINES AND ANALOGS THEREOF IL4, IL4I1, IL2 NPSR1 2255/4885GLO1 2953/4885ALDH1A1 1406/4885
US-20090318435-A1 PYRAZOLOPYRIDINES AND ANALOGS THEREOF IL4, IL2, IL4I1 NPSR1 2396/4885GLO1 3853/4885ALDH1A1 1688/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.